• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗细胞因子和抗RANKL抗体治疗类风湿关节炎和骨质疏松症的疗效

[Efficacy of anti-cytokines and anti-RANKL antibody for treatment of RA and osteoporosis].

作者信息

Okada Yosuke, Nawata Masao, Tanaka Yoshiya

机构信息

University of Occupational and Environmental Health, School of Medicine, The First Department of Internal Medicine.

出版信息

Clin Calcium. 2007 Nov;17(11):1762-8.

PMID:17982198
Abstract

Rheumatoid arthritis (RA) is characterized by inflammatory synovitis, erosive arthritis and joint destruction. Recent evidence indicates that inflammatory cytokines such as TNF-alpha or IL-6 plays a pathological role in joint destruction and osteoporosis and that anti-cytokine therapy or anti-RANKL antibody provides significant protection against the process.

摘要

类风湿性关节炎(RA)的特征是炎症性滑膜炎、侵蚀性关节炎和关节破坏。最近的证据表明,诸如肿瘤坏死因子-α或白细胞介素-6等炎性细胞因子在关节破坏和骨质疏松症中起病理作用,并且抗细胞因子疗法或抗核因子κB受体活化因子配体(RANKL)抗体可对该过程提供显著保护。

相似文献

1
[Efficacy of anti-cytokines and anti-RANKL antibody for treatment of RA and osteoporosis].抗细胞因子和抗RANKL抗体治疗类风湿关节炎和骨质疏松症的疗效
Clin Calcium. 2007 Nov;17(11):1762-8.
2
[Effects of biologic therapies on systemic osteoporosis in patients with rheumatoid arthritis].[生物疗法对类风湿关节炎患者全身性骨质疏松的影响]
Nihon Rinsho. 2009 May;67(5):996-1002.
3
[Anti-RANKL antibody for the treatment of rheumatoid arthritis].用于治疗类风湿性关节炎的抗RANKL抗体
Clin Calcium. 2011 Aug;21(8):1223-9.
4
[Cytokines in bone diseases. Anti-cytokine therapies for bone and joint diseases].[骨疾病中的细胞因子。用于骨与关节疾病的抗细胞因子疗法]
Clin Calcium. 2010 Oct;20(10):1545-52.
5
[Biochemical markers of bone turnover. New aspect. Therapy of rheumatoid arthritis for bone metabolic marker].[骨转换的生化标志物。新观点。类风湿关节炎骨代谢标志物的治疗]
Clin Calcium. 2009 Aug;19(8):1186-90.
6
[Secondary osteoporosis UPDATE. Rheumatoid arthritis and bone damage: trends in treatment].[继发性骨质疏松症最新进展。类风湿性关节炎与骨损伤:治疗趋势]
Clin Calcium. 2010 May;20(5):735-42.
7
[Expectation for alleviation of joint destruction in rheumatoid arthritis by new molecular targeting pharmaceutics including anti-rankle antibody].[通过包括抗RANKL抗体在内的新型分子靶向药物减轻类风湿性关节炎关节破坏的期望]
Clin Calcium. 2009 Mar;19(3):381-6.
8
[Biologic agents for the treatment of rheumatic diseases].[用于治疗风湿性疾病的生物制剂]
Clin Calcium. 2014 Jun;24(6):911-7.
9
[Rheumatoid arthritis and osteoporosis: trends in their treatments].[类风湿性关节炎与骨质疏松症:治疗趋势]
Nihon Rinsho. 2006 Dec;64(12):2359-66.
10
[Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Anti-bone resorbing treatment for rheumatoid arthritis.].[类风湿关节炎的诊断与治疗:迈向最佳实践。类风湿关节炎的抗骨吸收治疗。]
Clin Calcium. 2018;28(5):630-636.

引用本文的文献

1
Insights into the Role of Macrophage Polarization in the Pathogenesis of Osteoporosis.浅析巨噬细胞极化在骨质疏松发病机制中的作用。
Oxid Med Cell Longev. 2022 Jun 6;2022:2485959. doi: 10.1155/2022/2485959. eCollection 2022.